Utilising Heterogeneity: Using a Digital Database of Lung Cancers and Immune Profile to Complement Subjective Assessment (2018)

First Author: Haragan A.

Attributed to: Immune-checkpoint therapy in non-small cell lung carcinoma:molecular characterisation of tumour microenvironment to improve anti-PD1/PD-L1 drug class. funded by MRC

No abstract provided

Type: Conference/Paper/Proceeding/Abstract

Volume: 13

Parent Publication: JOURNAL OF THORACIC ONCOLOGY

Issue: 10

ISSN: 1556-0864